High Intensity Laser and Exercises in Knee OA
Unknown statusNot applicableNCT04751253
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of the study is to compare the effect of different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.
Study details
- Official title
- The Combined Effect Of Different Doses Of High-Intensity Laser And Traditional Exercise On Pain And Function In Patients With Chronic Knee Osteoarthritis
- Conditions
- Chronic Knee Osteoarthritis
- Interventions
- Device: High Intensity Laser Therapy
- Sponsor
- Cairo University
- Start date
- 2021-02-02
- Primary completion
- 2021-12-01
- Sex
- All
- Age range
- from 50 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. All subjects diagnosed as third degree chronic knee OA as determined by (Kellgren/Lawrence grading system) (Kellgren and Lawrence, 1957). 2. Aged between 50- 70 years 3. Persistent pain ≥4 on the visual analog scale (VAS) for more than 3 months in one or both knees. 4. Body mass index (BMI) ≤30 kg/m2. 5. Self-reported disability due to knee pain with a score of at least 25 on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). 6. All subjects who will participate in this study will read, sign and date an informed consent form which required by ethical committee of faculty of physical therapy, Cairo university Exclusion Criteria: Patients will be excluded if they have the following conditions: * History of joint replacement. * Symptoms or signs suggestive of another cause of knee pain. * Rheumatoid arthritis. * Steroid injection or knee surgery (previous six months). * acute inflammation around knee joint. * Underlying disease such as malignancy. * Infection or systemic disease of musculoskeletal system
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04751253